Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)

CompletedOBSERVATIONAL
Enrollment

695

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

June 3, 2020

Study Completion Date

June 3, 2020

Conditions
COVIDSARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Quantitative analysis of anti-SARS-CoV-2-antibodies

Plasma sampling will be collected and archived for subsequent quantitative analysis of anti-SARS-CoV-2 antibodies - IgG, IgM and IgA.

DIAGNOSTIC_TEST

SARS-CoV-2 diagnostic rapid test

The rapid test detects the presence of antibodies against SARS-CoV-2 by the immunochromatographic reaction.

Trial Locations (1)

128 01

Institute of Health Information and Statistics of the Czech Republic, Prague

All Listed Sponsors
collaborator

Ministry of Health, Czech Republic

OTHER_GOV

collaborator

Masaryk University

OTHER

collaborator

Institute for Clinical and Experimental Medicine

OTHER_GOV

collaborator

Brno University Hospital

OTHER

collaborator

St. Anne's University Hospital Brno, Czech Republic

OTHER

collaborator

Masaryk Memorial Cancer Institute

OTHER

collaborator

Regional Public Health Office of the South Moravian Region based in Brno, Czech Republic

UNKNOWN

collaborator

Public Health Office of the Capital City of Prague, Czech Republic

UNKNOWN

collaborator

Regional Public Health Office of the Central Bohemian Region based in Prague, Czech Republic

UNKNOWN

lead

Institute of Health Information and Statistics of the Czech Republic

OTHER_GOV

NCT04453280 - Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) | Biotech Hunter | Biotech Hunter